AREDS2 Exact Ingredients: Game-Changing Breakdown
.JPG)
- 01. Exact ingredients and typical doses
- 02. Historical context and why the formula changed
- 03. Why some products state 80 mg of zinc while others use 25 mg
- 04. Mechanisms and clinical effect sizes
- 05. How to read labels and confirm an exact AREDS2 product
- 06. Practical notes, safety, and clinician guidance
- 07. Common brand variations and label examples
- 08. Representative timeline and key dates
- 09. Quick checklist for consumers
- 10. Suggested citation for clinicians
Short answer: The AREDS2 exact daily formula recommended by the National Eye Institute (AREDS2) is vitamin C 500 mg, vitamin E 400 IU, zinc (zinc oxide) 25-80 mg (commonly 25 mg in modern products), copper (cupric oxide) 1-2 mg, lutein 10 mg, and zeaxanthin 2 mg, with beta-carotene removed due to lung-cancer risk in smokers; this combination is the evidence-based AREDS2 composition endorsed for patients with intermediate or unilateral advanced age-related macular degeneration (AMD).
Exact ingredients and typical doses
The AREDS2 formulation consists of six active nutrients given as a daily dose: vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc (zinc oxide) typically 25-80 mg, and copper (cupric oxide) 1-2 mg.
| Ingredient | Typical dose | Primary purpose |
|---|---|---|
| Vitamin C | 500 mg | Antioxidant; reduces oxidative stress in the retina. |
| Vitamin E | 400 IU | Lipid antioxidant protecting photoreceptor membranes. |
| Lutein | 10 mg | Macular carotenoid that filters blue light and concentrates in macula. |
| Zeaxanthin | 2 mg | Complementary macular carotenoid with lutein. |
| Zinc (oxide) | 25-80 mg (most producers now use 25 mg) | Supports retinal metabolism; original AREDS used 80 mg. |
| Copper (oxide) | 1-2 mg | Prevents copper deficiency from high zinc intake. |
Historical context and why the formula changed
The original AREDS trial (published 2001) used beta-carotene plus vitamins C and E, zinc 80 mg, and copper 2 mg and reported a meaningful slowing of progression to advanced AMD for certain patients; this is the AREDS original composition that established proof of concept.
AREDS2 (trial recruitment 2006-2008, main reports and pooled analyses published through 2013 and later secondary analyses) removed beta-carotene and tested adding lutein/zeaxanthin and omega-3s; the final clinical recommendation substituted lutein 10 mg and zeaxanthin 2 mg for beta-carotene because beta-carotene increased lung-cancer risk in current/former smokers.
Why some products state 80 mg of zinc while others use 25 mg
The original AREDS formulation used 80 mg zinc oxide; subsequent analyses and safety concerns (including higher genitourinary hospitalization rates with high zinc) prompted many manufacturers and clinicians to use 25 mg zinc in contemporary AREDS2-style products while keeping clinical efficacy similar.
Regulators and product labels therefore vary: many branded AREDS2 supplements list zinc 80 mg to mirror the original trials, while safer lower-zinc formulations (25 mg) have become common in the last decade.
Mechanisms and clinical effect sizes
AREDS and AREDS2 aim to reduce progression from intermediate to advanced AMD by supplying antioxidants and macular carotenoids that decrease oxidative damage and increase macular pigment density; AREDS reported ~25% risk reduction for progression in appropriately selected patients over 5 years, and AREDS2 analyses report similar or slightly improved benefit when lutein/zeaxanthin replace beta-carotene in non-smokers.
Secondary analyses published after 2013 showed hazard ratios for late AMD around 0.82 to 0.90 when lutein/zeaxanthin were used instead of beta-carotene in certain subgroups, equating to an approximate 10-20% relative risk reduction in specific comparisons.
How to read labels and confirm an exact AREDS2 product
Look for a supplement label that explicitly lists the six AREDS2 active ingredients and their milligram/IU amounts; the exact phrase "AREDS2 formula" on the label usually indicates alignment with the NEI recommendations but verify doses, especially zinc and copper.
Confirm that beta-carotene is absent (especially important for current or former smokers), that lutein is 10 mg and zeaxanthin 2 mg, and that copper is present at ~1-2 mg if zinc is provided at higher doses.
- Check dose - verify 500 mg vitamin C and 400 IU vitamin E are listed.
- Check carotenoids - lutein 10 mg and zeaxanthin 2 mg must be present.
- Check copper - present if zinc is high (to prevent deficiency).
- Confirm patient eligibility with an ophthalmologist (intermediate AMD or advanced in one eye).
- Compare the product label ingredient list and doses versus the AREDS2 table above.
- If a smoker or ex-smoker, choose a formulation without beta-carotene.
Practical notes, safety, and clinician guidance
AREDS2 supplements are indicated for patients with intermediate AMD or advanced AMD in one eye and are not proven to prevent AMD onset in people with no disease; discuss supplement use with the eye care clinician before starting long-term therapy.
High-dose zinc can cause gastrointestinal upset and interact with certain medications; copper is added to prevent zinc-induced copper deficiency, and beta-carotene should be avoided by smokers due to documented lung cancer risk.
Clinical quote: "AREDS2 should be reserved for patients with intermediate AMD or advanced AMD in one eye; the substitution of lutein and zeaxanthin for beta-carotene improved safety for smokers," - NEI summary guidance paraphrase, 2013-2015 reviews.
Common brand variations and label examples
Commercial products labeled "PreserVision AREDS2," "Bausch + Lomb AREDS2," and many third-party supplements follow the same six-ingredient pattern, but excipients (fillers, oils, tablet counts) and zinc dose (25 mg vs 80 mg) vary; always check the supplement facts panel for the precise milligram/IU amounts.
Representative timeline and key dates
AREDS (original) main results were reported in 2001 and established that high-dose antioxidants plus zinc reduced progression to advanced AMD in selected patients; AREDS2 started recruitment in the mid-2000s and published primary results and analyses through 2013-2015, after which the NEI and many manufacturers adopted the lutein/zeaxanthin substitution.
Quick checklist for consumers
- Diagnosis first - confirm intermediate or unilateral advanced AMD with an eye specialist.
- Read labels - verify exact milligram/IU doses for C, E, lutein, zeaxanthin, zinc, and copper.
- Avoid beta-carotene if you are a current or former smoker.
- Discuss interactions with your primary care physician (statins, chelators, other supplements).
Suggested citation for clinicians
Use the NEI AREDS/AREDS2 trial reports and the AREDS2 supplement fact tables when documenting patient counselling; the NEI FAQ and peer-reviewed AREDS2 secondary analyses are the authoritative sources for dose and subgroup effect data.
Expert answers to Areds2 Formula Ingredients Exact queries
What is the AREDS2 formula?
The AREDS2 formula is a specific supplement mix of vitamin C 500 mg, vitamin E 400 IU, lutein 10 mg, zeaxanthin 2 mg, zinc (oxide) commonly 25-80 mg, and copper (cupric oxide) 1-2 mg used for slowing progression of intermediate or unilateral advanced AMD.
Do I need a prescription for AREDS2?
No, AREDS2 supplements are typically sold over-the-counter, but clinical confirmation of AMD stage by an ophthalmologist is recommended before starting them.
Is beta-carotene in AREDS2?
No, beta-carotene was removed from AREDS2 because of increased lung-cancer risk in current/former smokers; lutein and zeaxanthin replaced it in the evidence-based formulation.
Which zinc dose is best?
Both 80 mg (original AREDS) and 25 mg zinc formulations have shown benefit, but many clinicians now favour 25 mg for a better safety profile while maintaining likely equivalent efficacy; consult your clinician for personalized advice.
Do AREDS2 supplements restore vision?
No, AREDS2 supplements are intended to slow progression of AMD, not to restore lost macular function; central vision already lost to advanced disease is generally not reversed by vitamins.